Pancreatic Endocrine Precursor Differentiation for Blood Glucose Lowering
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a significant need to develop conditions for establishing pluripotent stem cell lines that can be expanded to address clinical needs while retaining the potential to differentiate into pancreatic endocrine cells, pancreatic hormone expressing cells, or pancreatic hormone secreting cells.
Innovation Solution
A method is provided for producing pancreatic endocrine precursor cells by culturing pluripotent stem cells, differentiating them into cells expressing markers characteristic of the definitive endoderm lineage, then into pancreatic endoderm lineage, and finally into pancreatic endocrine precursor cells, using specific markers and differentiation protocols.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pluripotent stem cells are differentiated into pancreatic endocrine cells, then blood glucose levels can be lowered, but the efficiency and scalability of producing sufficient cell populations for clinical needs remains insufficient
Solution Approach 1:
The differentiation process is divided into distinct sequential stages: definitive endoderm formation, pancreatic endoderm specification, and pancreatic endocrine precursor cell generation. Each stage uses specific transcription factor combinations and culture conditions to guide cells through controlled developmental transitions, improving both efficiency and scalability
Solution Approach 2:
The patent establishes optimized culture protocols and transcription factor expression patterns in advance to pre-commit pluripotent stem cells toward the pancreatic endocrine lineage. This preliminary directional guidance ensures that when cells are expanded, they maintain their differentiation potential and efficiently produce sufficient populations for clinical transplantation
Data Source
AI summary
The present invention provides a method for lowering blood glucose levels in an animal by transplanting a population of pancreatic endocrine precursor cells into an animal.